Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00539006 · ClinicalTrials.gov registry record · Phase 4
Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 377
- Enrollment target
NCT00539006 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 377 participants.
The verdict
NCT00539006, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 377 participants
- Enrollment target
Study Summary
The purpose of this replicate study to FFU105927 is to provide data on subject preference of FFNS as compared with FPNS.
Interventions
- DRUG FPNS
- DRUG FFNS
- DRUG placebo FPNS
- DRUG placebo FFNS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 377 participants |
| Start Date | 2007-08 |
| Est. Completion | 2007-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00539006
The ClinicalTrials.gov registry entry for NCT00539006 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 377 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which FPNS is the first listed.
NCT00539006 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00539006 about?
NCT00539006 is a clinical study titled "Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS". The purpose of this replicate study to FFU105927 is to provide data on subject preference of FFNS as compared with FPNS.
What is the current status of trial NCT00539006?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 377 participants. The study started on 2007-08. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00539006?
The interventions under investigation include: FPNS (DRUG), FFNS (DRUG), placebo FPNS (DRUG), placebo FFNS (DRUG).
Who is sponsoring clinical trial NCT00539006?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.